Aclarion, Inc. (ACON) vs Renalytix plc - Sponsored ADR (RNLXY)
- Aclarion, Inc. ACON 1.85 −5.13%
- Renalytix plc - Sponsored ADR RNLXY 3.50 +3.24%
Aclarion, Inc. and Renalytix plc - Sponsored ADR are both Health Information Services companies. Renalytix plc - Sponsored ADR is the larger, with a market value of $17.2M against $5.6M — 3.1× the size. Aclarion, Inc. grew revenue faster over the last twelve months: 33.1% against −18.3%. Renalytix plc - Sponsored ADR has the higher net margin (−1,695.9% vs −10,987.6%) and the higher return on invested capital (0.00% vs −876.8%). Across the 16 metrics below, Renalytix plc - Sponsored ADR leads on 9 and Aclarion, Inc. on 7.
Valuation
Profitability
| Metric | ACON | RNLXY | Health Information Services median |
|---|---|---|---|
| Gross margin | 21.86% | 14.52% | 62.87% |
| Operating margin | (11,601.67%) | (1,087.73%) | (9.45%) |
| Net margin | (10,987.57%) | (1,695.90%) | (15.48%) |
| Free cash flow margin | (9,870.13%) | 0.00% | 0.00% |
| Return on equity | (58.97%) | 0.00% | (6.91%) |
| Return on assets | (56.09%) | 0.00% | (6.28%) |
| Return on invested capital | (876.79%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack